These findings suggest that using the RF classification model, the six DEG biomarkers (VWF, IL1RL1, DENND2B, MMP14, NAAA, and PANK1) can effectively distinguish IBD patients from healthy controls. This evidence concerns the gene VWF and inflammatory bowel disease.